Could Ozempic be a miracle drug for more than just weight loss? A new study suggests that the drug may reduce the risk of developing Alzheimer's.
Trump slams Hochul move to revive NYC congestion tax: ‘It will hurt workers, families, and businesses’In fact, they found it to work even better than the current most-effective drug for treating alcoholism on the market.Only three medications are currently approved for the treatment of AUD, and expert opinion maintains these options are not suitable for all patients, and relapse is commonplace.
Currently, the anti-addiction drug naltrexone is the most effective medicine approved for AUD, lowering the risk of hospitalization by 14%.GLP-1 drugs treat diabetes and stimulate weight loss by mimicking he naturally occurring hormone GLP-1, which signals the body that it is full. Over the course of the study, 60% of participants were hospitalized for alcohol use, but alcohol-related hospitalizations were dramatically lower among people who took a GLP-1 drug.Since the injectable was approved in 2017 to treat diabetes in adults, researchers have been testing its superpowers on other chronic diseases.Of the roughly 4,300 people prescribed semaglutide, there were 220 reports of hospitalization for AUD.
Lifestyle Addiction Alcohol Alcoholism Diabetes Ozempic Study Says Wellness
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study saysThe active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
Read more »
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: StudySemaglutide was associated with a 70% reduced risk when compared with insulin.
Read more »
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: StudySemaglutide was associated with a 70% reduced risk when compared with insulin.
Read more »
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: StudySemaglutide was associated with a 70% reduced risk when compared with insulin.
Read more »
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: StudySemaglutide was associated with a 70% reduced risk when compared with insulin.
Read more »
Ozempic could help reduce Alzheimer’s risk for some, study suggests: ‘Shifting the paradigm’Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.
Read more »